|
業務類別
|
Health Information Services |
|
業務概覽
|
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region. |
| 公司地址
| 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087 |
| 電話號碼
| +1 415 237-8272 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.certara.com |
| 員工數量
| 1576 |
| Ms. Rona S. Anhalt |
Chief Human Resources Officer |
-- |
08/04/2025 |
| Dr. Robert Aspbury, PhD |
President, Certara Predictive Technologies |
美元 457.67K |
08/04/2025 |
| Mr. Leif E. Pedersen |
President and Chief Commercial Officer |
美元 458.35K |
08/04/2025 |
| Mr. Daniel D. Corcoran |
Senior Vice President and General Counsel |
-- |
08/04/2025 |
| Mr. Jon Resnick |
Director and Chief Executive Officer |
-- |
03/04/2026 |
| Mr. John E. Gallagher, III |
Senior Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 606.32K |
26/02/2026 |
| Mr. Adrian McKemey, PhD |
President, Certara Drug Development Solutions |
美元 366.67K |
08/04/2025 |
|
|
| Ms. Nancy Killefer |
Independent Director |
03/04/2026 |
| Mr. Stephen M. McLean |
Independent Director |
03/04/2026 |
| Ms. Rosemary A. Crane, M.B.A. |
Independent Director |
03/04/2026 |
| Mr. David Spaight |
Independent Director |
03/04/2026 |
| Mr. James E. Cashman, III |
Chairman of the Board |
03/04/2026 |
| Mr. Eran Broshy |
Independent Director |
03/04/2026 |
| Mr. Matthew M. Walsh |
Independent Director |
03/04/2026 |
| Ms. Cynthia Lynne Collins |
Independent Director |
31/03/2026 |
| Mr. Jon Resnick |
Director and Chief Executive Officer |
03/04/2026 |
| Mr. Arjun Bedi |
Independent Director |
03/04/2026 |
| Dr. John V. W. Reynders |
Independent Director |
03/04/2026 |
|
|
|
|
